Stockpicker Comparison Tool
Nothing here is comparable yet for these companies.
Revenue Growth
OMRX
-82.09%
▼ -43.89%
GMED
5.94%
▼ -21.10%
Gross Margin
OMRX
9.68%
▼ -20.46%
GMED
69.42%
▲ 0.23%
Free Cash Flow
OMRX
-$166.95K
▲ $137.59K
GMED
$176.57M
▲ $13.82M
Net Debt / EBITDA
OMRX
-5.34
▼ -65.27
GMED
-0.55
▲ 0.03
Operating Margin
OMRX
184.58%
▲ 105.14%
GMED
23.10%
▲ 1.58%
P/E Ratio
OMRX
0.36
▼ -0.04
GMED
—